On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...
PARIS, May 19, 2015 /PRNewswire/ -- Abbott announced today that it has received CE Mark for the latest advancement of its Absorb stent system, called Absorb GT1™, which combines the world's first ...
University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent ...
WASHINGTON, DC—Use of the Absorb bioresorbable vascular scaffold (BVS; Abbott Vascular) appears to be a safe and effective option for the treatment of in-stent restenosis, but acute and late ...
Abbott said it will monitor bioabsorbable stent implantations in Europe, following a high rate of heart attacks in European Absorb GT1 patients, plus a separate FDA safety alert regarding adverse ...
Two new meta-analyses evaluating the safety and effectiveness of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) suggest the “dissolving” stent is as safe and effective as an ...
FRESNO, Calif. (KFSN) -- The last time Giacomo Ciabattini walked into Saint Agnes Medical Center in Northeast Fresno, he was in a much bigger hurry. He was having a major cardiac episode on ...
DENVER -- As new 3- and 4-year data emerged from the ABSORB clinical trials, the FDA updated its cautions to healthcare professionals about continuing risk seen with the first-generation Absorb ...
CHICAGO, IL — Due to low commercial sales, Abbott will stop selling the first-generation bioresorbable Absorb coronary stent, the company announced [1]. Abbott will discontinue all sizes of Absorb ...
University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent ...
WASHINGTON (March 18, 2017) -- Patients receiving the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), a dissolving stent to open clogged vessels around the heart, showed outcomes ...